OTTAWA, Ontario – Nov. 22, 2022 – Corsa Security announced today that it has added new capabilities to its Corsa Security Orchestrator (CSO) software so that network security professionals can quickly and easily scale inspection capacity to terabits of traffic. The development means enterprises and service providers can group virtual firewalls—from leading vendors like Palo Alto Networks and Fortinet—into clusters and load balance traffic across the group of virtual firewalls to build large blocks of inspection capacity. With the industry embracing 5G and its higher bandwidth, latency and security demands, this now makes it possible to ensure security functions are keeping pace and inspecting all traffic flowing through the network at any given time.

Enterprises and service providers alike are adapting their networks and embracing 5G, including private 5G networks, Multi-Access Edge Computing (MEC) and network slicing. However, with the vast amount of IoT devices and large numbers of user sessions with huge volumes of video and conference streaming, there is a dramatic increase in bandwidth, making it a challenge for security functions to keep up. With the updated Corsa Security Orchestrator, network and security teams now have the capability to software load balance across clusters of virtual firewalls and scale inspection capacity. As traffic continues to grow, the team can upgrade with a single-click in the CSO, adding more virtual firewall resources to the existing cluster.

“To protect this new 5G-driven infrastructure, security must be flexible yet able to quickly scale to very high levels,” explains Eduardo Cervantes, CEO of Corsa Security. “There is really only one way to get this flexibility, which is to deploy virtual firewalls where and when needed that inspect all the traffic flowing through the network. But then you also need to scale these virtual firewall clusters, which is now possible with our solution that offers push-button, software load balancing for terabits of inspection capacity.”
What makes this all possible is the Corsa Security Orchestrator, which binds the worlds of network security (the firewall inspection) to the underlying network (server infrastructure). It performs key functions required for large-scale firewall virtualization and flexible traffic inspection at any scale, including:

• Automation of bootstrap and initial configuration of NGFW VMs
• Provisioning of policy settings to the VMs in a zero-touch way
• Software load balancing for optimal virtual firewall performance within clusters
• Flow tracking for intelligent traffic steering to and from VMs
• Health check mechanism to monitor VM and system performance
• Push-button virtual firewall cluster upgrades to scale to Tbps.

Security professionals can now deploy, scale and optimize virtual firewalls for terabits of traffic inspection with speed, simplicity and savings.

TORONTO & DALLAS–(BUSINESS WIRE)– Perimeter Medical Imaging AI, Inc. (TSX-V: PINK)(OTC: PYNKF) (FSE: 4PC) announced another commercial placement of its flagship Perimeter S-Series OCT system at a second hospital within one of the largest healthcare networks in North Texas, which is part of a major national healthcare system. Perimeter is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs.

Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “Approximately six weeks ago, we announced the commercial placement of our Perimeter S-Series OCT system within a national healthcare network. I am pleased to report that we have now completed the second commercial installation at another hospital within this major healthcare system. This further validates a core part of our commercial strategy as we expand use within key integrated delivery network customers. Further, we are receiving timely, positive feedback that the value provided by our technology is resonating with not only our end-users but other stakeholders within the healthcare system as well.”

About Perimeter Medical Imaging AI, Inc.

Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company’s ticker symbol “PINK” is a reference to the pink ribbons used during Breast Cancer Awareness Month.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains statements that constitute “forward-looking information” within the meaning of applicable Canadian securities legislation. In this news release, words such as “may,” “would,” “could,” “will,” “likely,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management’s future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, plans and objectives of, or involving, Perimeter. Without limitation, information regarding the potential benefits of Perimeter S-Series OCT and Perimeter B-Series OCT, the expected benefits of Perimeter’s updated version of its ImgAssist AI, and the expected details regarding Perimeter’s ongoing clinical trials, are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management’s good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter’s control. Such forward-looking statements reflect Perimeter’s current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter’s financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter’s Management Discussion and Analysis for the year ended December 31, 2022, which is available on Perimeter’s SEDAR+ profile at https://www.sedarplus.ca, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws.